Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             144 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antimetastatic activities of heparins and modified heparins. Experimental evidence Borsig, Lubor
 2010
 125 S2 p. S66-S71
6 p.
 artikel
2 Author index 2010
 125 S2 p. S193-S196
4 p.
 artikel
3 Bleeding complications associated with anticoagulant therapy in patients with cancer Trujillo-Santos, Javier
 2010
 125 S2 p. S58-S61
4 p.
 artikel
4 Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact Elice, F.
 2010
 125 S2 p. S55-S57
3 p.
 artikel
5 Cancer in males and risk of venous thromboembolism Beyer-Westendorf, Jan
 2010
 125 S2 p. S155-S159
5 p.
 artikel
6 Cancer prevention and vitamin K antagonists: An overview Pengo, Vittorio
 2010
 125 S2 p. S103-S105
3 p.
 artikel
7 Editorial Board 2010
 125 S2 p. ii-
1 p.
 artikel
8 Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score Connolly, Gregory C.
 2010
 125 S2 p. S1-S7
7 p.
 artikel
9 Experimental and clinical effects of anticoagulants on cancer progression Van Noorden, Cornelis J.F.
 2010
 125 S2 p. S77-S79
3 p.
 artikel
10 Heparanase procoagulant effects and inhibition by heparins Nadir, Yona
 2010
 125 S2 p. S72-S76
5 p.
 artikel
11 Lessons from French national guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients Farge, Dominique
 2010
 125 S2 p. S108-S116
9 p.
 artikel
12 Mechanisms coupling the hemostatic system to colitis-associated cancer Palumbo, Joseph S.
 2010
 125 S2 p. S39-S43
5 p.
 artikel
13 Membrane microparticles in VTE and cancer Key, Nigel S.
 2010
 125 S2 p. S80-S83
4 p.
 artikel
14 Membrane microvesicles: Macromessengers in cancer disease and progression Castellana, Donatello
 2010
 125 S2 p. S84-S88
5 p.
 artikel
15 OC-08 Adjuvant bemiparin in small cell lung cancer: results from the ABEL study Lecumberri, R.
 2010
 125 S2 p. S163-
1 p.
 artikel
16 OC-13 Enhanced expression of Mda-9/syntenin induced through the tissue-factor pathway in melanoma promotes tumor cell migration and invasion Boukerche, H.
 2010
 125 S2 p. S164-
1 p.
 artikel
17 OC-04 Expression of protease activated receptor-1 and tissue factor in human cancers determined by gene expression profiling and laser capture microdissection Haslinger, C.
 2010
 125 S2 p. S162-
1 p.
 artikel
18 OC-06 Frequency, types and management of bleeding episodes in acquired von Willebrand syndrome: a five-year prospective study in a cohort of 18 patients with chronic lympho-myeloproliferative disorders (LPD/MPD) Rezzonico, F.
 2010
 125 S2 p. S162-
1 p.
 artikel
19 OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study) Maraveyas, A.
 2010
 125 S2 p. S161-
1 p.
 artikel
20 OC-15 Hemostatic activation, fibrinolysis and angiogenesis are increased in patients with advanced prostate cancer (PC) and decrease in response to hormonal therapy Arnason, J.E.
 2010
 125 S2 p. S165-
1 p.
 artikel
21 OC-07 Heparin-antagonist PMX-60056 rapidly and completely reverses heparin anticoagulation in man McAllister, R.E.
 2010
 125 S2 p. S162-S163
2 p.
 artikel
22 OC-05 Inhibition of tissue factor by Ixolaris reduces primary tumor growth and metastasis in a murine model of melanoma Da Silva de Oliveira, A.
 2010
 125 S2 p. S162-
1 p.
 artikel
23 OC-10 Involvement of cancer cell-derived microparticles on thrombus formation in vivo Thomas, G.M.
 2010
 125 S2 p. S163-
1 p.
 artikel
24 OC-01 Prognostic relevance of asymptomatic venous thromboembolism in patients with cancer Dentali, F.
 2010
 125 S2 p. S161-
1 p.
 artikel
25 OC-03 Randomized phase II trial of an oral factor Xa inhibitor in patients with metastatic cancer on chemotherapy Levine, M.N.
 2010
 125 S2 p. S161-S162
2 p.
 artikel
26 OC-11 Residual vein thrombosis (RVT) for assessing the optimal management of deep vein thrombosis in cancer patients: an interim analysis of the cancer DACUS study Malato, A.
 2010
 125 S2 p. S164-
1 p.
 artikel
27 OC-14 Reversible posterior leukoencephalopathy syndrome: the role of von Willebrand Factor and ADAMTS13 in children with ALL during induction therapy Carneiro, J.D.A.
 2010
 125 S2 p. S165-
1 p.
 artikel
28 OC-09 Tissue factor-bearing particles released from tumor cells: Relationship of particle size to procoagulant activity Francis, J.L.
 2010
 125 S2 p. S163-
1 p.
 artikel
29 OC-12 Tissue factor phosphorylation requires protease activated receptor-2 expression: Correlation with the prognosis of human breast cancer Rydén, L.
 2010
 125 S2 p. S164-
1 p.
 artikel
30 Open issues on bleeding and thrombosis in acute promyelocytic leukemia Sanz, Miguel A.
 2010
 125 S2 p. S51-S54
4 p.
 artikel
31 PO-40 Abnormal D-dimer level as the first evidence of tumor recurrence: a case report Junqueira, P.L.
 2010
 125 S2 p. S176-S177
2 p.
 artikel
32 PO-74 Allergic skin lesions are a rare adverse event under anticoagulant therapy with fondaparinux – results of a prospective investigation Schindewolf, M.
 2010
 125 S2 p. S186-
1 p.
 artikel
33 PO-89 Analysis of the thrombin generation activity expressed by acute promyelocytic leukemia (APL) cells with and without treatment with arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) Diani, E.
 2010
 125 S2 p. S190-
1 p.
 artikel
34 PO-06 Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon Ferrante, N.
 2010
 125 S2 p. S167-
1 p.
 artikel
35 PO-29 Calibrated automated thrombogram in cancer patients Kolyadko, N.
 2010
 125 S2 p. S173-S174
2 p.
 artikel
36 PO-10 Cancer associated thrombosis: the Thai perspective Angchaisuksiri, P.
 2010
 125 S2 p. S168-
1 p.
 artikel
37 PO-15 Cancer-related venous thrombosis: residual vein thrombosis improves screening for occult cancer Malato, A.
 2010
 125 S2 p. S170-
1 p.
 artikel
38 PO-64 Cancer, VTE, prognosis and prophylaxis Petrova, O.
 2010
 125 S2 p. S183-
1 p.
 artikel
39 PO-27 CD 142 expression on the leukemic cells from children Lipay, N.
 2010
 125 S2 p. S173-
1 p.
 artikel
40 PO-60 Changes in procoagulant potential of microparticles in patients with acute myeloid leukemia during chemotherapeutic treatment: behavior of blast-derived microparticles in a phospholipid- and tissue factor-depleted endogenous thrombin potential assay van Aalderen, M.C.
 2010
 125 S2 p. S182-
1 p.
 artikel
41 PO-21 Characterization of tumor cells thrombin generation (TG) capacity by the calibrated automated assay (CAT) Marchetti, M.
 2010
 125 S2 p. S171-S172
2 p.
 artikel
42 PO-23 Chemotherapy-induced venous thromboembolism is not due to endothelial cell activation Kirwan, C.C.
 2010
 125 S2 p. S172-
1 p.
 artikel
43 PO-26 Coagulation activation in myeloid leukemia: the role of integrin CD11b, leukocytosis, blast cells and promyelocytes Sukrisman, L.
 2010
 125 S2 p. S173-
1 p.
 artikel
44 PO-82 Dabigatran etexilate blocks breast cancer progression in vitro and in a 4T1 breast cancer tumor model in mice DeFeo, K.
 2010
 125 S2 p. S188-
1 p.
 artikel
45 PO-33 D-dimer testing to determine duration of anticoagulation and risk of occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study Cosmi, B.
 2010
 125 S2 p. S175-
1 p.
 artikel
46 PO-13 Deep vein thrombosis of the upper limbs. A retrospective study Tasinato, R.
 2010
 125 S2 p. S169-
1 p.
 artikel
47 PO-36 Detection of circulating tissue factor activity in the plasma of a patient with glioblastoma multiforme: a potential cause of cancer-associated hypercoagulability? Francis, J.L.
 2010
 125 S2 p. S176-
1 p.
 artikel
48 PO-52 Determination of thrombin generation (TG) and procoagulant activity (PCA) expressed by circulating microparticles (MP) in essential thrombocythemia (ET) patients Leuzzi, A.
 2010
 125 S2 p. S179-S180
2 p.
 artikel
49 PO-92 Disabled-2 modulates platelet activation and heterotypic interactions with leukocytes Finkielstein, C.V.
 2010
 125 S2 p. S190-S191
2 p.
 artikel
50 PO-76 Effectiveness of recombinant factor VIIa in haemorragic cancer-related disseminated intravascular coagulation: a case report Pierfranceschi, M. Giorgi
 2010
 125 S2 p. S186-S187
2 p.
 artikel
51 PO-90 Effect of betaine on tissue factor expression in human and tumor-associated host cells Napoleone, E.
 2010
 125 S2 p. S190-
1 p.
 artikel
52 PO-85 Effects of an anthocyanin (delphinidin-3-glucoside) from wild blueberries on the proangiogenic and prothrombotic properties of endothelial cells Bonacina, G.
 2010
 125 S2 p. S189-
1 p.
 artikel
53 PO-75 Efficacy and safety of fondaparinux in the management of strongly suspected heparin-induced thrombocytopenia (HIT): the key role of an early diagnosis Barco, S.L.
 2010
 125 S2 p. S186-
1 p.
 artikel
54 PO-51 Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy Trappenburg, M.C.
 2010
 125 S2 p. S179-
1 p.
 artikel
55 PO-58 Endothelial circulating microparticles in thromboembolism and cancer Radu, C.
 2010
 125 S2 p. S181-S182
2 p.
 artikel
56 PO-59 Endothelial microparticles levels as markers of tumor response to treatment with anti-angiogenesis agents Tillo, O.
 2010
 125 S2 p. S182-
1 p.
 artikel
57 PO-57 Evaluation of ETP-mipa, a microparticle sensitive thrombin generation assay Molenaar, P.J.
 2010
 125 S2 p. S181-
1 p.
 artikel
58 PO-54 Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay and an automated procoagulant assay Debaugnies, F.
 2010
 125 S2 p. S180-
1 p.
 artikel
59 PO-68 Evolution of long term use of tinzaparin (6 months) in patients with DVT: a prospective study of our clinic Dimakakos, E.
 2010
 125 S2 p. S184-
1 p.
 artikel
60 PO-69 Evolution of long term use of tinzaparin (12 months) in patients with pulmonary embolism: a prospective study of our clinic Dimakakos, E.
 2010
 125 S2 p. S184-
1 p.
 artikel
61 PO-84 Expression of Tissue Factor (TF) and growth factor receptors on pancreatic cell lines: correlation with TF activity and cell invasion Echrish, H.
 2010
 125 S2 p. S188-S189
2 p.
 artikel
62 PO-63 Filling the evidence gap in palliative care: a qualitative study to identify the research agenda for thromboprophylaxis in advanced cancer Noble, S.I.R.
 2010
 125 S2 p. S183-
1 p.
 artikel
63 PO-31 Hypercoagulation in colon and breast cancer patients undergoing surgery as revealed by increased platelet function Koliou, P.
 2010
 125 S2 p. S174-
1 p.
 artikel
64 PO-46 Hyperhomocysteinemia is sensitive marker of thrombotic risk in patients with multiple myeloma Shmeleva, V.
 2010
 125 S2 p. S178-
1 p.
 artikel
65 PO-43 Hypofibrinolysis in patients with venous thromboembolism and cancer Spiezia, L.
 2010
 125 S2 p. S177-
1 p.
 artikel
66 PO-65 Incidence and causes of heparin-induced skin lesions – results of a prospective investigation Schindewolf, M.
 2010
 125 S2 p. S183-
1 p.
 artikel
67 PO-03 Incidence and risk factors for venous thromboembolism in cancer patients qualifying for chemotherapy van Sluis, G.L.
 2010
 125 S2 p. S166-
1 p.
 artikel
68 PO-02 Incidence of venous thromboembolism and prophylaxis use in ambulatory cancer patients receiving chemotherapy Panizo, E.
 2010
 125 S2 p. S166-
1 p.
 artikel
69 PO-05 Incidental pulmonary emboli in cancer patients – a single centre experience Donnelly, O.G.
 2010
 125 S2 p. S167-
1 p.
 artikel
70 PO-28 Increased thrombin generation (TG) potential of platelets from myeloproliferative neoplasms Panova-Noeva, M.
 2010
 125 S2 p. S173-
1 p.
 artikel
71 PO-91 Leptin upregulates human breast cancer cell line MCF7 expression of tissue factor: a possible role of tumor necrosis factor Napoleone, E.
 2010
 125 S2 p. S190-
1 p.
 artikel
72 PO-67 Long-term treatment for cancer patients with deep vein thrombosis or pulmonary embolism – a randomized controlled trial Kleinjan, A.
 2010
 125 S2 p. S184-
1 p.
 artikel
73 PO-35 Loss of angiogenic activity and improvement of hemostatic variables in patients with gastrointestinal stromal tumors (GIST) under Imatinib therapy: a biological evaluation Russo, L.
 2010
 125 S2 p. S175-
1 p.
 artikel
74 PO-71 Low molecular weight heparin (LMWH) administration in cancer patients (PTS) with hypercoagulability related complications and carrying brain metastases: a case series Vitale, F.V.
 2010
 125 S2 p. S185-
1 p.
 artikel
75 PO-61 Measurement of procoagulant activity of microparticles by the fibrin generation test as a predictor for venous thrombosis in cancer patients Kleinjan, A.
 2010
 125 S2 p. S182-
1 p.
 artikel
76 PO-83 Nadroparin inhibits A549 human lung adenocarcinoma cell proliferation through down-regulation of cyclin B1 and G2/M phase cell-cycle arrest Carmazzi, Y.
 2010
 125 S2 p. S188-
1 p.
 artikel
77 PO-19 On the role of protease-activated receptors-1 and -2 (PAR-1 and PAR-2) in human glioblastoma cell lines Dutra-Oliveira, A.
 2010
 125 S2 p. S171-
1 p.
 artikel
78 PO-20 Organic metallic complexes with antiplatelet and antineoplasmatic effects Karkabounas, S.
 2010
 125 S2 p. S171-
1 p.
 artikel
79 PO-81 Oversulfated dermatan sulfate (DS) from ascidians, but not mammalian DS, inhibit P-selectin in vitro and metastasis in vivo Kozlowski, E.O.
 2010
 125 S2 p. S188-
1 p.
 artikel
80 PO-24 Oxidative changes in blood plasma of patients with myelodysplastic syndromes Suttnar, J.
 2010
 125 S2 p. S172-
1 p.
 artikel
81 PO-42 Plasma fibrinogen and survival after cancer diagnosis Meade, T.
 2010
 125 S2 p. S177-
1 p.
 artikel
82 PO-37 Plasma TF levels in colon cancer patients do not alter after total tumor excision Koliou, P.
 2010
 125 S2 p. S176-
1 p.
 artikel
83 PO-53 Platelet derived microparticles induce factor XII mediated thrombin generation Spronk, H.M.
 2010
 125 S2 p. S180-
1 p.
 artikel
84 PO-86 Platelet proteins modified by oxidative stress in myelodysplastic syndromes Pimkova, K.
 2010
 125 S2 p. S189-
1 p.
 artikel
85 PO-25 Platelets as the biomarkers of cancer therapy efficiency Matveeva, A.
 2010
 125 S2 p. S172-S173
2 p.
 artikel
86 PO-56 Potential contribution of microparticles to the thrombotic risk in high grade glioma Sartori, M.T.
 2010
 125 S2 p. S181-
1 p.
 artikel
87 PO-32 Prediction of venous thromboembolism in cancer patients by measuring thrombin generation – Results from the Vienna Cancer and Thrombosis Study (CATS) Ay, C.
 2010
 125 S2 p. S174-S175
2 p.
 artikel
88 PO-34 Preoperative plasma D-dimer is a predictor of one-year survival in colorectal cancer patients: A prospective clinical cohort study Stender, M. Tornby
 2010
 125 S2 p. S175-
1 p.
 artikel
89 PO-07 Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis Dentali, F.
 2010
 125 S2 p. S167-S168
2 p.
 artikel
90 PO-04 Prevalence of venous thromboembolism in upper gastrointestinal cancer at time of diagnosis Larsen, A.C.
 2010
 125 S2 p. S167-
1 p.
 artikel
91 PO-30 Procoagulant phospholipids in patients with venous thromboembolism and cancer Spiezia, L.
 2010
 125 S2 p. S174-
1 p.
 artikel
92 PO-88 Prognostic significance of angiogenesis in breast carcinoma Kanchev, E.
 2010
 125 S2 p. S190-
1 p.
 artikel
93 PO-87 Prognostic value of vascular endothelial growth factor (VEGF) serum level and immunohistochemical expression in non-treated patient with chronic lymphocytic leukemia Antic, D.
 2010
 125 S2 p. S189-
1 p.
 artikel
94 PO-77 Prophylaxis of DIC and thrombophilia during chemotherapy in gynecologic cancer patients Makatsaria, A.
 2010
 125 S2 p. S187-
1 p.
 artikel
95 PO-09 Pulmonary embolism as an incidental finding in ambulatory cancer outpatients. Characteristics and outcome Bozas, G.
 2010
 125 S2 p. S168-
1 p.
 artikel
96 PO-44 Retrospective analysis of coagulation parameters at epidural anaesthesia catheter withdrawal after esophageal resection Anveden, P.A.
 2010
 125 S2 p. S177-S178
2 p.
 artikel
97 PO-41 Role of PAI-1 in the differential diagnosis of hepatic veno-occlusive disease complicating hematopoietic stem cell transplantation: study in a pediatric population Sartori, M.T.
 2010
 125 S2 p. S177-
1 p.
 artikel
98 PO-12 Safety and feasibility of a diagnostic algorithm combining clinical probability, D-dimer test and ultrasonography in suspected upper extremity deep vein thrombosis Kleinjan, A.
 2010
 125 S2 p. S169-
1 p.
 artikel
99 PO-39 Selected haemostatic parameters in patients with multiple myeloma and venous thromboembolism Staško, J.
 2010
 125 S2 p. S176-
1 p.
 artikel
100 PO-78 Selection and purification of blood clotting factor VII suitable for therapeutic and treatment purposes Madych, S.
 2010
 125 S2 p. S187-
1 p.
 artikel
101 PO-22 Sodium butyrate stimulates over-expression of TFPI in CHO-K1 cells Skretting, G.
 2010
 125 S2 p. S172-
1 p.
 artikel
102 PO-79 Stable overexpression and knockdown of TFPI in breast cancer cells suggest antitumor properties of TFPI Stavik, B.
 2010
 125 S2 p. S187-
1 p.
 artikel
103 PO-17 Surgical stress promotes the development of metastatic disease by a coagulation-dependent mechanism Auer, R.
 2010
 125 S2 p. S170-S171
2 p.
 artikel
104 Potential of new anticoagulants in patients with cancer Weitz, Jeffrey I.
 2010
 125 S2 p. S30-S35
6 p.
 artikel
105 PO-45 The effect of 8- and 24-hour whole-blood storage on coagulation parameters Muth, H.
 2010
 125 S2 p. S178-
1 p.
 artikel
106 PO-80 The effect of LMWHs on the formation of metastases: a pilot study Blaskó, G.
 2010
 125 S2 p. S187-S188
2 p.
 artikel
107 PO-62 The implementation of a simple step-wise intervention which dramatically improved the thromboprophylaxis rate in medical cancer patients Saha, A.
 2010
 125 S2 p. S182-S183
2 p.
 artikel
108 PO-48 The influence of paraprotein on bleeding complications in multiple myeloma Djunic, I.
 2010
 125 S2 p. S178-S179
2 p.
 artikel
109 PO-72 The likelihood of acute pulmonary embolism in emergency department (ED) patients is not lower among patients taking warfarin Nordenholz, K.
 2010
 125 S2 p. S185-
1 p.
 artikel
110 PO-50 The role of breast cancer cells microparticles in thrombogenicity following chemotherapy Aharon, A.
 2010
 125 S2 p. S179-
1 p.
 artikel
111 PO-66 The use of extended peri-operative low molecular weight heparin to improve disease-free survival following surgical resection of colon cancer: a pilot randomized controlled trial Carrier, M.
 2010
 125 S2 p. S184-
1 p.
 artikel
112 PO-70 Thromboelastography is an important tool in the anticoagulant management of patient with tumoral thrombosis: a case report Junqueira, P.L.
 2010
 125 S2 p. S184-S185
2 p.
 artikel
113 PO-38 Thrombotic risk factors in intensive care unit patients from a cancer hospital: a prospective evaluation de Meis, E.
 2010
 125 S2 p. S176-
1 p.
 artikel
114 PO-18 Tissue factor expression is associated with MMP and uPA/PAI secretion in adherent small cell lung cancer cells Hahn, N.
 2010
 125 S2 p. S171-
1 p.
 artikel
115 PO-55 Treatment of the monocytic leukemia cell line THP-1 with anthracyclines increases cellular tissue factor activity and release of tissue factor positive microparticles Boles, J.
 2010
 125 S2 p. S180-S181
2 p.
 artikel
116 PO-49 Tumors are the major source of tissue factor-positive microparticles in a mouse model of pancreatic cancer Wang, J.-G.
 2010
 125 S2 p. S179-
1 p.
 artikel
117 PO-47 Uncarboxylated matrix Gla-protein (ucMGP) and osteocalcin (ucOC) increase postoperatively after major abdominal cancer and orthopedic surgery Anveden, P.A.
 2010
 125 S2 p. S178-
1 p.
 artikel
118 PO-14 Unsuspected venous thromboembolic disease as a finding of staging procedures in oncology Cravero, P.
 2010
 125 S2 p. S169-S170
2 p.
 artikel
119 PO-16 Upper arm deep venous thrombosis in peripheral inserted central venous catheter (PICC): data in our oncologic patients population Romagnoli, E.
 2010
 125 S2 p. S170-
1 p.
 artikel
120 PO-08 Venous thromboembolism in cancer outpatients receiving chemotherapy for solid tumors Font, C.
 2010
 125 S2 p. S168-
1 p.
 artikel
121 PO-11 Venous thromboembolism in patients receiving preoperative chemotherapy for gastric cancer Larsen, A.C.
 2010
 125 S2 p. S169-
1 p.
 artikel
122 PO-01 Venous thromboembolism in patients with lung cancer Font, C.
 2010
 125 S2 p. S166-
1 p.
 artikel
123 PO-73 Venous thromboembolism (VTE) prophylaxis in colorectal cancer surgery patients: the observational SCALA study Ageno, W.
 2010
 125 S2 p. S185-S186
2 p.
 artikel
124 PO-93 Very low molecular weight heparins (LMWH) retain the capacity to inhibit endothelial cell migration and capillary-like tube formation induced by tumor cells Vignoli, A.
 2010
 125 S2 p. S191-
1 p.
 artikel
125 Predictive value of tissue factor bearing microparticles in cancer associated thrombosis Zwicker, Jeffrey I.
 2010
 125 S2 p. S89-S91
3 p.
 artikel
126 Preface Falanga, Anna
 2010
 125 S2 p. ix-
1 p.
 artikel
127 Prevention and treatment of venous thromboembolism among patients with cancer: The American Society of Clinical Oncology Guidelines Lyman, Gary H.
 2010
 125 S2 p. S120-S127
8 p.
 artikel
128 Role of the tissue factor pathway in the biology of tumor initiating cells 1 1 Delphine Garnier and Chloe Milsom equally contributed as first authors. Garnier, Delphine
 2010
 125 S2 p. S44-S50
7 p.
 artikel
129 Targeting anionic phospholipids on tumor blood vessels and tumor cells Thorpe, Philip E.
 2010
 125 S2 p. S134-S137
4 p.
 artikel
130 Tests predictive of thrombosis in cancer Ay, Cihan
 2010
 125 S2 p. S12-S15
4 p.
 artikel
131 The “common soil hypothesis”: Evidence from population studies? Donati, Maria Benedetta
 2010
 125 S2 p. S92-S95
4 p.
 artikel
132 The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients Streiff, Michael B.
 2010
 125 S2 p. S128-S133
6 p.
 artikel
133 The role of activated protein C in cancer progression van Sluis, Geerte L.
 2010
 125 S2 p. S138-S142
5 p.
 artikel
134 The roles of anticoagulants in patients with cancer Lee, Agnes Y.Y.
 2010
 125 S2 p. S8-S11
4 p.
 artikel
135 Thromboprophylaxis during chemotherapy in patients with advanced cancer Agnelli, Giancarlo
 2010
 125 S2 p. S17-S20
4 p.
 artikel
136 Thromboprophylaxis during chemotherapy: NO Levine, Mark N.
 2010
 125 S2 p. S16-
1 p.
 artikel
137 Thrombosis in Paroxysmal Nocturnal Hemoglobinuria – insights into the role of complement in thrombosis Weitz, Ilene C.
 2010
 125 S2 p. S106-S107
2 p.
 artikel
138 Thrombotic complications in children with haematologic malignacies Putti, Maria Caterina
 2010
 125 S2 p. S151-S154
4 p.
 artikel
139 Tissue-factor fusion proteins induce occlusion of tumor vessels Schwöppe, Christian
 2010
 125 S2 p. S143-S150
8 p.
 artikel
140 Tissue factor in cancer progression and angiogenesis Ruf, Wolfram
 2010
 125 S2 p. S36-S38
3 p.
 artikel
141 Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism Cosmi, Benilde
 2010
 125 S2 p. S62-S65
4 p.
 artikel
142 Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma Wun, Ted
 2010
 125 S2 p. S96-S102
7 p.
 artikel
143 Venous thromboembolism (VTE) in cancer patients. ESMO Clinical Recommendations for prevention and management Mandalà, Mario
 2010
 125 S2 p. S117-S119
3 p.
 artikel
144 VTE prophylaxis for the medical patient: where do we stand? – A focus on cancer patients Cohen, Alexander T.
 2010
 125 S2 p. S21-S29
9 p.
 artikel
                             144 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland